"This week our office will be open Mon-Fri 8:00am - 4:00pm by appointment only. It is our primary goal to keep everyone safe, so please be patient with us while we take the appropriate precautions to minimize health and welfare risks to our patients and team members. Learn more on our website."

During the past decade, Carmel Mountain Vision Care conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Carmel Mountain Vision Care" are "Astigmatism" (1 trials), "Corneal Disease" (1 trials), "Hypersensitivity" (1 trials) and "Refractive Errors" (1 trials). Many other conditions were trialed in "Carmel Mountain Vision Care" in a lesser frequency.

Most popular intervention types in "Carmel Mountain Vision Care" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "SynergEyes A2 Hybrid Contact Lens" (1 trials), "SynergEyes Hybrid (paflufocon D hem-iberfilcon A) Contact Lens" (1 trials) and "SynergEyes Hybrid (petrafocon A hem-larafilcon A) Hybrid Contact Lens" (1 trials). Other intervention names were less common.

The vast majority of trials in "Carmel Mountain Vision Care" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Carmel Mountain Vision Care". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Carmel Mountain Vision Care, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Carmel Mountain Vision Care, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".